Citation: R. Kolloch et E. Offers, Vasopeptidase inhibition, a new pharmacological principle in the treatmentof hypertension and heart failure, DEUT MED WO, 126(47), 2001, pp. 1342-1347
Authors:
Zanchetti, A
Hansson, L
Dahlof, B
Elmfeldt, D
Kjeldsen, S
Kolloch, R
Larochelle, P
McInnes, GT
Mallion, JM
Ruilope, L
Wedel, H
Citation: A. Zanchetti et al., Effects of individual risk factors on the incidence of cardiovascular events in the treated hypertensive patients of the Hypertension Optimal Treatment Study, J HYPERTENS, 19(6), 2001, pp. 1149-1159
Citation: R. Kolloch et E. Offers, Vasopeptidase inhibition - New action principle for the treatment of hypertension and cardiac insufficiency, INTERNIST, 42(2), 2001, pp. 290-296
Authors:
Waeber, B
Leonetti, G
Kolloch, R
McInnes, GT
Citation: B. Waeber et al., Compliance with aspirin or placebo in the hypertension optimal treatment (HOT) study, J HYPERTENS, 17(7), 1999, pp. 1041-1045